Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does the PEMT rs7946 T allele reduce phosphatidylcholine synthesis and promote liver fat accumulation?

The PEMT rs7946 T allele reduces endogenous phosphatidylcholine synthesis, impairing VLDL assembly and promoting hepatic triglyceride accumulation.

PlausibleJuly 1, 202619 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

PEMT rs7946 T allele can reduce endogenous phosphatidylcholine synthesis, which can impair VLDL export and promote hepatic fat accumulation.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the T allele partially reduces PEMT enzymatic activity, lowering endogenous phosphatidylcholine production and altering the ER membrane PC/PE ratio. This membrane disruption impairs apoB100 lipidation and VLDL budding, causing triglycerides to be retained in hepatocytes and driving hepatic steatosis. The mechanism links a specific genetic variant to a secretory bottleneck that promotes liver fat accumulation.

Verified conclusion

The PEMT gene encodes the enzyme responsible for the endogenous synthesis of phosphatidylcholine (PC) via the methylation of phosphatidylethanolamine (PE) in the liver. Genetic variations in this pathway significantly impact hepatic lipid export and overall metabolic health.

Mechanistic explanations

  • Enzymatic reduction: The PEMT rs7946 (V175M) T allele acts as a partial loss-of-function variant, directly reducing PEMT enzymatic activity by approximately 30%.
  • Membrane disruption: Rather than just lowering bulk cellular PC, this genetic impairment specifically alters the crucial PC/PE ratio within the endoplasmic reticulum (ER) membrane.
  • Assembly failure: An optimal ER membrane PC/PE ratio is strictly required for the cotranslational lipidation of apolipoprotein B100 (apoB100) by microsomal triglyceride transfer protein (MTP). Disrupting this membrane environment impairs apoB100 stabilization and blocks proper VLDL particle budding.

Clinical and physiological evidence

  • Impaired secretion: Genetic models of PEMT deficiency (Pemt−/−) exhibit a ~50% reduction in triglyceride secretion and a ~70% drop in apoB100-VLDL export.
  • Hepatic lipid trapping: Because VLDL is the primary vehicle for exporting neutral lipids, compromised VLDL assembly causes triglycerides to become physically trapped within hepatocytes. This intracellular pooling shifts the metabolic equilibrium toward cytosolic lipid droplet storage.
  • Steatosis susceptibility: This secretory bottleneck directly drives hepatic fat accumulation, increasing susceptibility to non-alcoholic fatty liver disease (NAFLD), especially when dietary choline intake is insufficient to offset the genetic reduction in endogenous PC synthesis.

Bottom line

  • The PEMT rs7946 T allele reduces endogenous PC synthesis by 30%, altering the hepatic ER membrane PC/PE ratio and impairing VLDL assembly, which directly traps triglycerides in the liver and promotes hepatic steatosis.

References

  1. Genetic variants in phosphatidylethanolamine N-methyltransferase and methylenetetrahydrofolate dehydrogenase influence biomarkers of choline metabolism when folate intake is restricted. — pmc.ncbi.nlm.nih.gov ↗
  2. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD) — pmc.ncbi.nlm.nih.gov ↗
  3. PEMT gene - Choline Metabolism & Deficiency - Gene Food — mygenefood.com ↗
  4. Phosphatidylethanolamine N-methyltransferase - Wikipedia — en.wikipedia.org ↗
  5. An unexpected requirement for phosphatidylethanolamine N ... — pubmed.ncbi.nlm.nih.gov ↗
  6. LIPIDS AND LIPOPROTEINS An Unexpected Requirement for ... — sciencedirect.com ↗
  7. VLDL Biogenesis and Secretion: It Takes a Village - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. The active synthesis of phosphatidylcholine is required for ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  9. Phosphatidylethanolamine N-methyltransferase: from Functions to ... — pmc.ncbi.nlm.nih.gov ↗
  10. Phosphatidylcholine biosynthesis and lipoprotein secretion in rat ... — open.library.ubc.ca ↗
  11. Role of phosphatidylcholine biosynthesis in the regulation ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  12. Steatotic Liver Disease (SLD): Background, Etiology, Pathophysiology — emedicine.medscape.com ↗
  13. Lipid and Lipoprotein Metabolism in Liver Disease - Endotext - NCBI — ncbi.nlm.nih.gov ↗
  14. Dysfunctional VLDL metabolism in MASLD - Nature — nature.com ↗
  15. NAFLD: Mechanisms, Treatments, and Biomarkers - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  16. Metabolic-associated fatty liver disease and lipoprotein metabolism — pmc.ncbi.nlm.nih.gov ↗
  17. Blocking VLDL secretion causes hepatic steatosis but does not ... — pubmed.ncbi.nlm.nih.gov ↗
  18. Metabolic-associated fatty liver disease and lipoprotein metabolism — sciencedirect.com ↗
  19. Lack of phosphatidylethanolamine N-methyltransferase ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→